AXSM
Axsome Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$155.81
−0.85%Forward multiples
Based on analyst estimates
- P/E forward
- 114.34x
- P/E 2026E
- —
- P/E 2027E
- 39.69x
- P/E 2028E
- 13.75x
- P/S forward
- 6.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 97.97x
- Price / sales
- 10.51x
- Price / cash flow
- -114.53x
Enterprise value
- Enterprise value
- $8.1B
- EV / sales
- 10.38x
- EV / EBITDA
- -45.77x
- EV / EBIT
- -42.75x
- Market cap
- $8.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026